
Numerous zzso viral zzso derived from a variety of strains have zzso efficacy with limited or no toxicity to normal zzso While all modes of administration were determined to be safe in patients with solid zzso zzso to current standard of care, this therapeutic approach requires further improvements to achieve zzso zzso 

We review the most promising clinical developments with several zzso zzso The focus is on zzso and clinical findings with zzso zzso zzso including zzso zzso and zzso zzso that, to date, are the most studied zzso zzso Cellular pathways reported to play a role in zzso cell killing are reviewed as potential targets for the development of more effective zzso zzso 

The most promising clinical outcomes for zzso zzso have been reported for zzso zzso and zzso virus zzso expressing the zzso zzso However, highly zzso and selective zzso zzso have been developed that interact zzso with zzso drugs in model zzso We anticipate that by zzso the cellular targets for synergistic cancer cell killing in response to zzso zzso and drugs such as zzso and zzso zzso greatly improved zzso therapies will result in the near zzso 

